SCHEMBL25848597

SCHEMBL25848597

C=C(C)C(=O)OCC(COc1ccc2cc(-c3ccc(CCCCC)cc3CC(F)(F)F)c(=O)oc2c1)CC(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.36
MAOA P21397 1/20 0.36
SLC10A1 Q14973 1/20 0.35
NPC1 O15118 7/20 0.35
RAB9A P51151 7/20 0.35
PTPN7 P35236 1/20 0.34
KDM4E B2RXH2 5/20 0.33
HPGD P15428 3/20 0.33
GLA P06280 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625007 0.96 MAOB (0.37) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL22625108 0.91 MAOB (0.36) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL22625050 0.90 NPC1 (0.39) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL22624954 0.90 MAOB (0.35) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL21735752 0.87 S1PR1 (0.39) MAOBMAOASLC10A1S1PR1S1PR3
SCHEMBL25849217 0.87 MAOB (0.39) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL25849050 0.86 MAOB (0.38) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL22625303 0.86 THRB (0.39) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL25854728 0.85 MAOB (0.38) MAOBMAOASLC10A1NPC1RAB9A
SCHEMBL22624946 0.84 MAOB (0.40) MAOBMAOASLC10A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885MAOA 2922/4885SLC10A1 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.